Medical innovators from more than 20 countries gathered in Boao Lecheng, China this June for the Global Recruitment Conference for International Innovative Drugs and Medical Devices 2026.

Efferon joined the event and presented the clinical benefits of next-generation multimodal hemoadsorption for critically ill patients.

China is an important next step in Efferon's international journey, and we are looking forward to bringing our technologies closer to Chinese clinicians and patients in the near future.

Many thanks to the Boao Lecheng team and the conference organizers for the warm welcome and the opportunity to connect with colleagues from around the world.

Stay tuned!